Sensei Biotherapeutics
SNSE
SNSE
23 hedge funds and large institutions have $2.05M invested in Sensei Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$41.2K | |
| 2 | +$17.9K | |
| 3 | +$817 | |
| 4 |
Morgan Stanley
New York
|
+$151 |
Top Sellers
| 1 | -$158K | |
| 2 | -$13.1K | |
| 3 | -$484 | |
| 4 |
BlackRock
New York
|
-$277 |
| 5 |
Two Sigma Advisers
New York
|
-$277 |